AG真人官方

TriMas Corp. (TRS) Form 144 filing discloses a proposed sale of 63,965 common shares鈥攁bout 0.16 % of the 40.64 M shares outstanding鈥攙alued at roughly $2.24 M. The seller intends to execute the trade through Fidelity Brokerage Services on Nasdaq around 29 Jul 2025. All shares were acquired in 2021 via stock-option exercises and restricted-stock vesting; no prior sales were reported in the last three months. Form 144 is a notice, not an executed sale, but it signals potential insider liquidity activity. Given the small percentage of total shares, the transaction should have limited market impact unless accompanied by further disposals.

On 07/29/2025 Orrstown Financial Services (ORRF) filed a Form 4 for EVP & Chief Experience Officer Michael Jaeger. The executive sold 642 common shares on 07/28/2025 at $34.25 (transaction code 鈥淪鈥�). After the sale, Jaeger directly owns 745 unrestricted shares and 4,198 restricted shares that vest over the next three years.

No derivative securities were involved and no purchases were reported. The disposition reduced Jaeger鈥檚 freely tradable stake by roughly 46 % (642 of 1,387 previously held). No other insiders are covered in this filing.

Aureus Greenway Holdings Inc. (AGH) 鈥� Form 4 insider transaction: On 07/25/2025, Chief Executive Officer, Director and 10% owner Chi-Ping Cheung executed two sales through his wholly owned entity, Chrome Fields Asset Management LLC.

• Common stock: 2,000,000 shares sold (Code S) at $0.975 per share, trimming indirect holdings to 2,352,000 shares. The sale accounts for roughly 46% of his prior common-stock position and totals about $1.95 million.
• Series A preferred: 4,000,000 shares disposed at $0.01 each, eliminating all preferred ownership.

Following the transactions, Cheung remains an insider with indirect ownership of 2.352 million common shares but no preferred shares. The sizeable divestiture by the company鈥檚 top executive may raise investor concerns about insider sentiment and near-term valuation pressure, while the exit from preferred shares modestly simplifies AGH鈥檚 capital structure.

Cryoport (CYRX) Form 4 filing: On 07/24/2025 President & CEO Jerrell Shelton exercised 25,000 stock options at a $5 strike price (transaction code M) and retained every share. His direct common-stock holdings rose to 1,012,419 shares. The option grant, issued in 2015, vested monthly over four years; 50,000 options remain outstanding after the exercise. No shares were sold, representing an estimated $125,000 cash outlay and a modest increase in insider ownership. The move appears to be routine compensation-related activity rather than a strategic shift, yet the additional personal investment can be viewed as a sign of management confidence.

Form 4 highlights: Dean DeSantis, co-personal representative of the Estate of founder Carl DeSantis and a 10% owner of Celsius Holdings (CELH), reported the physical settlement of three tranches of a variable prepaid forward (VPF) entered 1 Aug 2022. The tranches matured 22-24 Jul 2025 and were settled on 23-25 Jul 2025.

Transaction details: Each tranche required GRAT 1, LLC鈥攃ontrolled by the estate鈥攖o deliver 300,000 CELH shares (adjusted for splits) to an unaffiliated buyer. Because the volume-weighted average price on each maturity date exceeded the $40.1588 cap, GRAT 1 received the maximum cash amount specified by the VPF formula and transferred the full share number. In total, 900,000 shares were disposed of at an implied cap price of $40.1588.

Ownership impact: Indirect beneficial ownership fell from roughly 3.6 million to 2.7 million shares, a 25% reduction. Shares are held indirectly through GRAT 1; DeSantis retains shared voting and dispositive power. No derivative positions remain after settlement.

Aehr Test Systems (AEHR) filed Form 144 disclosing a proposed insider sale under SEC Rule 144.

• Securities to be sold: 5,000 common shares.
• Broker: Charles Schwab Corp., Westlake, TX.
• Estimated market value: US $106,600 (implies 鈮� $21.32 per share).
• Sale window: on or about 25 Jul 2025 via NASDAQ.
• Origin of shares: acquired 11 Jul 2023 as compensation from the issuer.
• Shares outstanding: 29,771,410; planned sale equals 鈮� 0.017 % of total.

No other sales during the past three months were reported. The filer attests to having no undisclosed material adverse information and acknowledges Rule 10b5-1 and anti-fraud obligations.

Synopsys, Inc. (SNPS) 鈥� SEC Form 3 filed for GC & Corporate Secretary Janet Lee. The filing is triggered by the 17 Jul 2025 completion of Synopsys鈥� merger with Ansys, Inc. Lee now reports:

• Common stock: 8,298 shares held directly.
• Converted Ansys RSUs 鈫� Synopsys RSUs:
  • 5,385 RSUs vest 31 Dec 2025.
  • 878 RSUs vest quarterly to 3 Mar 2026.
  • 4,894 RSUs vest quarterly to 1 Mar 2027.
  • 8,705 RSUs vest one-third on 16 Feb 2026, then quarterly to 16 Feb 2028.

The RSU conversion ratio was 0.6952; Ansys common shares were exchanged for 0.3399 SNPS shares plus $199.91 cash each. Lee files as a single reporting person and is classified as an officer, not a 10 % owner. No indirect holdings are disclosed.

Aehr Test Systems (AEHR) has filed a Form 144, indicating a proposed sale of 18,000 common shares through Fidelity Brokerage Services. The shares have an aggregate market value of $356,972.22 and represent roughly 0.06% of the 29.77 million shares outstanding. The filer plans to execute the sale on or about 07/22/2025. The shares were acquired via an employee stock option granted on 08/17/2018 and are to be paid for in cash upon exercise. No other sales by the filer were reported during the past three months.

The notice contains no earnings data or operational updates; it simply alerts the market to a small potential insider transaction. Given the limited size relative to the company鈥檚 float, the filing is unlikely to be material to AEHR鈥檚 valuation or liquidity.